Evidence map›Paper›PMID 39554615›Full record

ArticleComputational and structural biotechnology journal2024

NaCTR: Natural product-derived compound-based drug discovery pipeline from traditional oriental medicine by search space reduction.

Seunghwan Jung, Kwansoo Kim, Seunghyun Wang, Manyoung Han, Doheon Lee

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Bicuculline fromComputational and structural biotechnology journal · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Seunghwan JungDepartment of Bio and Brain Engineering, KAIST, Daejeon 34141, Republic of Korea.
Kwansoo KimDepartment of Bio and Brain Engineering, KAIST, Daejeon 34141, Republic of Korea.
Seunghyun WangDepartment of Bio and Brain Engineering, KAIST, Daejeon 34141, Republic of Korea.
Manyoung HanDepartment of Bio and Brain Engineering, KAIST, Daejeon 34141, Republic of Korea.
Doheon LeeDepartment of Bio and Brain Engineering, KAIST, Daejeon 34141, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The drug discovery pipelines require enormous time and cost, albeit their infamously high risk of failures. Reducing such risk has therefore been the utmost goal in the process. Recently, natural products (NPs) in traditional oriental medicine (TOM) have come into the spotlight for their efficacy and safety supported throughout the history. Not only that, with the ever-increasing repository of various biological datasets, many data-driven

Indexed as

In silico drug discoveryNatural productParkinson's diseasePKToxicity

Identifiers

PMID39554615
PMCPMC11564001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.